One More Score: CBO Projects HHS Rebate Proposal Would Boost Part D Spending $170bn
HHS downplays latest attempt to predict “complex behavior changes to a broken system.”
You may also be interested in...
A plan to ban rebates in the US Medicare outpatient drug program was a signature policy proposal of the Trump Administration – but has never been implemented. A Senate bill tests a different approach to the same goal of ensuring that price concessions by manufacturers translate into lower prices charged at the pharmacy counter.
A focus on transparency, impacts of vertical integration and concerns about increasing government costs shows in the Congressional Budget Office score of the Senate pharmacy benefits manager reform bill.
Bill aims to lower patient costs in part by engaging the US Federal Trade Commission to shed light on pharmacy benefit manager transactions with health plans, manufacturers and pharmacies.